Next Article in Journal
Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook
Previous Article in Journal
Testing a Benchtop Wet-Milling Method for Preparing Nanoparticles and Suspensions as Hospital Formulations
Previous Article in Special Issue
Assessments of the In Vitro and In Vivo Linker Stability and Catabolic Fate for the Ortho Hydroxy-Protected Aryl Sulfate Linker by Immuno-Affinity Capture Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometric Assay
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(4), 483; https://doi.org/10.3390/pharmaceutics13040483
Action Date Notes Link
article xml file uploaded 2 April 2021 07:18 CEST Original file -
article xml uploaded. 2 April 2021 07:18 CEST Update -
article pdf uploaded. 2 April 2021 07:18 CEST Version of Record -
article supplementary file uploaded. 2 April 2021 07:18 CEST - https://www.mdpi.com/1999-4923/13/4/483#supplementary
article html file updated 2 April 2021 07:20 CEST Original file -
article xml file uploaded 2 April 2021 08:14 CEST Update -
article xml uploaded. 2 April 2021 08:14 CEST Update https://www.mdpi.com/1999-4923/13/4/483/xml
article pdf uploaded. 2 April 2021 08:14 CEST Updated version of record https://www.mdpi.com/1999-4923/13/4/483/pdf
article html file updated 2 April 2021 08:15 CEST Update -
article html file updated 11 April 2021 00:55 CEST Update -
article html file updated 11 April 2021 01:29 CEST Update -
article html file updated 4 August 2021 01:43 CEST Update -
article html file updated 4 August 2021 01:56 CEST Update -
article html file updated 25 July 2022 10:28 CEST Update https://www.mdpi.com/1999-4923/13/4/483/html
Back to TopTop